Roundup Caused Man's Cancer: Jury

Roundup Caused Man's Cancer: Jury

Troy Powers
March 21, 2019

Monsanto's Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium November 27, 2017.

The jury in San Francisco federal court in a unanimous ruling found Roundup, one of the world's most widely-used weed killers, to be responsible for the cancer of California resident Edwin Hardeman.

Bayer in a statement on Tuesday said it was disappointed with the jury's initial decision. Monsanto said studies have established that the active ingredient in Roundup, glyphosate, is safe.

Bayer, which closed on the purchase of Monsanto last summer, faces more than 11,000 USA lawsuits alleging that glyphosate causes cancer.

It was reported in April past year that Bayer sold 3.6 per cent stake to Temasek for 3 billion euros at 96.77 euros per share.

"Regulatory authorities around the world consider glyphosate-based herbicides as safe when used as directed", the group has said, highlighting "800 rigorous studies" of chemical's effects. They predict that paying to resolve more than 11,000 related USA lawsuits, which Bayer inherited with its acquisition of Monsanto Co., could cost as much as US$5 billion. "The day of reckoning for Bayer and its cancer-causing weedkiller is getting closer".

In the next phase of the federal trial, Mr Hardeman's lawyers will present evidence, including internal Monsanto documents, that could show the company knew the dangers of Roundup and glyphosate and attempted to cover them up.

The next Roundup trial is scheduled to begin in California state court in Oakland on March 28 next week, involving a couple who claim Roundup has caused their non-Hodgkin's lymphoma. In that case, a California state court jury awarded a former school groundskeeper damages eventually reduced by a judge to $78.6 million.

Israeli rabbi, wounded in Palestinian attack, dies - hospital
Netanyahu, who leads the most rightwing government in Israeli history, relies on support from settlers in the West Bank. Palestinians seek to establish a state there and in the Gaza Strip, with East Jerusalem as its capital.

Baader Helvea analyst Markus Mayer noted that Bayer management announced ambitious targets in December.

Activist investor Elliott already holds a stake of less than 3 percent in Bayer, Reuters disclosed past year.

Bayer had claimed that jury was overly influenced by plaintiffs' lawyers allegations of corporate misconduct and did not focus on the science.

The two United States cases have turned on a 2015 finding from the International Agency for Research on Cancer (IARC), an arm of the World Health Organization, that Roundup is "probably carcinogenic".

Bayer questions that finding: "The IARC opinion is inconsistent with 40 years of scientific research on glyphosate". The jury found that it was on Tuesday.

FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019.

Chhabria has scheduled another bellwether trial for May and a third trial is likely to take place this year. The trial will now proceed to the damages phase.

According to European Union health authorities, "experts, with only one exception, concluded that glyphosate is unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard to its carcinogenic potential".